Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
Gosens MJ, van Kempen LC, van de Velde CJ, van Krieken JH, Nagtegaal ID. Gosens MJ, et al. Among authors: van kempen lc, van krieken jh, van de velde cj. Mod Pathol. 2007 Feb;20(2):221-32. doi: 10.1038/modpathol.3800733. Mod Pathol. 2007. PMID: 17361206 Free article. Clinical Trial.
Stromal responses in human primary melanoma of the skin.
van Kempen LC, van Muijen GN, Ruiter DJ. van Kempen LC, et al. Among authors: van muijen gn. Front Biosci. 2005 Sep 1;10:2922-31. doi: 10.2741/1748. Front Biosci. 2005. PMID: 15970546 Review.
GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D, Alexaki VI, Pierrat MJ, Hoek KS, Dennler S, Van Kempen L, Bertolotto C, Ballotti R, Saule S, Delmas V, Mauviel A. Javelaud D, et al. Among authors: van kempen l. Pigment Cell Melanoma Res. 2011 Oct;24(5):932-43. doi: 10.1111/j.1755-148X.2011.00893.x. Epub 2011 Aug 18. Pigment Cell Melanoma Res. 2011. PMID: 21801332
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.
van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem GE, van den Oord J, Feunteun J, Spatz A. van Kempen LC, et al. Among authors: van den oord j, van rijk af. Sci Transl Med. 2016 Dec 14;8(369):369ra177. doi: 10.1126/scitranslmed.aai9188. Sci Transl Med. 2016. PMID: 27974665
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice.
Steeghs EMP, Vink GR, Elferink MAG, Voorham QJM, Gelderblom H, Nagtegaal ID; PATH Consortium Members; Grünberg K, Ligtenberg MJL; PATH consortium members. Steeghs EMP, et al. J Clin Pathol. 2021 Oct 21;75(10):706-11. doi: 10.1136/jclinpath-2021-207865. Online ahead of print. J Clin Pathol. 2021. PMID: 34675090 Free PMC article.
Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation.
van Herpen CM, van der Voort R, van der Laak JA, Klasen IS, de Graaf AO, van Kempen LC, de Vries IJ, Boer TD, Dolstra H, Torensma R, van Krieken JH, Adema GJ, De Mulder PH. van Herpen CM, et al. Among authors: van kempen lc, van der laak ja, van der voort r, van krieken jh. Int J Cancer. 2008 Nov 15;123(10):2354-61. doi: 10.1002/ijc.23756. Int J Cancer. 2008. PMID: 18729197 Clinical Trial.
Melanoma progression in a changing environment.
van Kempen LC, van Muijen GN, Ruiter DJ. van Kempen LC, et al. Among authors: van muijen gn. Eur J Cell Biol. 2007 Feb;86(2):65-7. doi: 10.1016/j.ejcb.2006.12.001. Epub 2007 Jan 22. Eur J Cell Biol. 2007. PMID: 17241688 Review. No abstract available.
170 results